Status:
UNKNOWN
Characterization of the Phenotypic Markers of B Cell Lymphocytes in Rheumatoid Arthritis
Lead Sponsor:
Assiut University
Conditions:
Autoimmune Diseases
Eligibility:
All Genders
18-80 years
Brief Summary
Rheumatoid Arthritis (RA): RA is a chronic inflammatory autoimmune disease that primarily affects the small joints, eventually leading to bone erosion and an inability to move (1). Several immune cel...
Detailed Description
B cell population: B lymphocytes play several critical roles in the pathogenesis of rheumatoid arthritis. They are the source of the rheumatoid factors (RF) and anti-cyclic-citrullinated peptide (ant...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patient diagnosed as Rheumatoid arthritis that fulfilled ACR/EULAR Criteria (American College of Rheumatology/European League Against Rheumatism).
- (8) Age \>18 Years.
- b. Exclusion criteria:
- Diagnosed patients with other autoimmune disease or other infections.
- Pregnant patients.
Exclusion
Key Trial Info
Start Date :
January 3 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 20 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03793270
Start Date
January 3 2019
End Date
August 20 2020
Last Update
January 4 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.